Patents by Inventor Severin Thompson

Severin Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20230365605
    Abstract: The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
    Type: Application
    Filed: October 11, 2022
    Publication date: November 16, 2023
    Inventors: Adrian L. Gill, Andreas Buckl, Elena S. Koltun, Naing Aay, Arlyn A. Tambo-ong, Severin Thompson, Micah James Gliedt, John E. Knox, James Cregg, Anne V. Edwards, Yang Liu, G. Leslie Burnett
  • BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20230148450
    Abstract: The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
    Type: Application
    Filed: March 2, 2020
    Publication date: May 11, 2023
    Inventors: Andreas BUCKL, James Joseph CREGG, Naing AAY, Arlyn A. TAMBO-ONG, Elena S. KOLTUN, Adrian Liam GILL, Severin THOMPSON, Micah J Gliedt
  • BICYCLIC HETEROCYCLYL COMPOUNDS AND USES THEREOF
    Publication number: 20230096028
    Abstract: The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are Q pharmaceutical compositions comprising the same.
    Type: Application
    Filed: March 2, 2020
    Publication date: March 30, 2023
    Inventors: James Joseph CREGG, Andreas BUCKL, Naing AAY, Arlyn A. TAMBO-ONG, Elena S. KOLTUN, Adrian Liam GILL, Severin THOMPSON, Micah J. Gliedt
  • BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20220135584
    Abstract: The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
    Type: Application
    Filed: March 2, 2020
    Publication date: May 5, 2022
    Inventors: Andreas BUCKL, James Joseph CREGG, Naing AAY, Arlyn A. TAMBO-ONG, Elena S. KOLTUN, Adrian Liam GILL, Severin THOMPSON, Micah J Gliedt
  • Bicyclic heteroaryl compounds and uses thereof
    Patent number: 11168102
    Abstract: The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same. Modulators of SOS1 have the following general structure of the Formula (II), or a pharmaceutically acceptable salt or a stereoisomer thereof, wherein the variables are as defined herein.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: November 9, 2021
    Assignee: Revolution Medicines, Inc.
    Inventors: Adrian L. Gill, Andreas Buckl, Elena S. Koltun, Naing Aay, Arlyn A. Tambo-ong, Severin Thompson, Micah James Gliedt, John E. Knox, James Cregg, Anne V. Edwards, Yang Liu, G. Leslie Burnett
  • BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
    Publication number: 20210139517
    Abstract: The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 13, 2021
    Inventors: Adrian L. Gill, Andreas Buckl, Elena S. Koltun, Naing Aay, Arlyn A. Tambo-ong, Severin Thompson, Micah James Gliedt, John E. Knox, James Cregg, Anne V. Edwards, Yang Liu, G. Leslie Burnett